P

PharmaBioSource, Inc.

Profile set up by Edverise AI
Is this your business? Become an Edverise partner & Claim Now →
View Website

Set Up By Edverise AI

Edverise AI built this profile by analyzing thousands of data points across the web. If you own this business, become an Edverise partner to manage and update your profile.
Become an Edverise Partner

Overview

2 - 9

Employees

2020

Year Founded

ABOUT PHARMABIOSOURCE, INC.

Consulting

Our team consists of engineers, scientists, manufacturing professionals, and finance experts who possess a wealth of experience in the pharmaceutical sector. We develop comprehensive and innovative solutions that facilitate successful outcomes in life science transactions. Thanks to our industry knowledge, extensive contacts, global reach, and demonstrated success, we are a highly valued resource for companies, facilities, and therapeutic asset deals in the life sciences.
LANGUAGES SPOKEN
English
HIGHLIGHTS

2 - 9

Employees

2020

Year Founded

Services
Focus
Industries
Clients
Services Provided
40% Writing Services
40% Business Consulting Services
20% Financial Advisory & Consulting

About the Team

OUR STORY
PharmaBioSource originated over 20 years ago when founder and CEO William (Bill) Wiederseim identified a unique industry need while assisting a multinational pharmaceutical company with selling a plant. Recognizing the demand for a firm that comprehended both drug engineering and manufacturing alongside financial and accounting expertise, he assembled a team of pharmaceutical executives, engineers, scientists, and finance professionals to establish a specialized entity dedicated to managing biopharma transactions from start to finish. Since then, PharmaBioSource has evolved into a multinational organization operating across three continents, successfully facilitating over 100 transactions involving therapeutic assets and pharmaceutical facilities totaling more than $4 billion. Their longstanding commitment remains delivering expert guidance, innovative strategies, and actionable intelligence to global biopharmaceutical companies, service providers, and investors worldwide.
Goodisnotgoodenough.